Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;113:1196-1202
Published online before print February 27, 2006, doi: 10.1161/CIRCULATIONAHA.105.602094
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
113/9/1196    most recent
CIRCULATIONAHA.105.602094v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nahrendorf, M.
Right arrow Articles by Ertl, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nahrendorf, M.
Right arrow Articles by Ertl, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Cardio-renal physiology/pathophysiology
Right arrow Remodeling
Right arrow Cardiovascular imaging agents/Techniques
Right arrow CT and MRI
Right arrow Animal models of human disease
Right arrow Heart failure - basic studies
Right arrow Imaging
Right arrowRelated Article

(Circulation. 2006;113:1196-1202.)
© 2006 American Heart Association, Inc.


Heart Failure

Factor XIII Deficiency Causes Cardiac Rupture, Impairs Wound Healing, and Aggravates Cardiac Remodeling in Mice With Myocardial Infarction

Matthias Nahrendorf, MD; Kai Hu, MD; Stefan Frantz, MD; Farouc A. Jaffer, MD, PhD; Ching-Hsuan Tung, PhD; Karl-Heinz Hiller, PhD; Sabine Voll; Peter Nordbeck, MD; David Sosnovik, MD; Stefan Gattenlöhner, MD; Mikhail Novikov, MD; Gerhard Dickneite, PhD; Guy L. Reed, MD; Peter Jakob, PhD; Anthony Rosenzweig, MD; Wolfgang R. Bauer, MD, PhD; Ralph Weissleder, MD, PhD; Georg Ertl, MD

From the Medizinische Klinik und Poliklinik I, Universität Würzburg, Würzburg, Germany (M. Nahrendorf, K.H., S.F., P.N., S.G., W.R.B., G.E.); Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass (M.N., F.A.J., C.T., D.S., R.W.); Physikalisches Institut (EP5), Universität Würzburg, Würzburg, Germany (K.H., S.V., P.J.); Cardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass (M. Novikov, A.R.); ZLB Behring, Marburg, Germany (G.D.); and Cardiology Division, Department of Medicine, Medical College of Georgia, Augusta (G.L.R.).

Correspondence to Dr Georg Ertl, Medizinische Universitätsklinik, Universität Würzburg, Josef Schneider-Strasse 2, 97080 Würzburg, Germany. E-mail Ertl_G{at}medizin.uni-wuerzburg.de

Received May 27, 2005; de novo received November 16, 2005; revision received December 16, 2005; accepted December 23, 2005.

Background— Identification of key molecular players in myocardial healing could lead to improved therapies, reduction of scar formation, and heart failure after myocardial infarction (MI). We hypothesized that clotting factor XIII (FXIII), a transglutaminase involved in wound healing, may play an important role in MI given prior clinical and mouse model data.

Methods and Results— To determine whether a truly causative relationship existed between FXIII activity and myocardial healing, we prospectively studied myocardial repair in FXIII-deficient mice. All FXIII–/– and FXIII/+ (FXIII activity <5% and 70%) mice died within 5 days after MI from left ventricular rupture. In contradistinction, FXIII–/– mice that received 5 days of intravenous FXIII replacement therapy had normal survival rates; however, cardiac MRI demonstrated worse left ventricular remodeling in these reconstituted FXIII–/– mice. Using a FXIII-sensitive molecular imaging agent, we found significantly greater FXIII activity in wild-type mice and FXIII–/– mice receiving supplemental FXIII than in FXIII–/– mice (P<0.05). In FXIII–/– but not in reconstituted FXIII–/– mice, histology revealed diminished neutrophil migration into the MI. Reverse transcriptase–polymerase chain reaction studies suggested that the impaired inflammatory response in FXIII–/– mice was independent of intercellular adhesion molecule and lipopolysaccharide-induced CXC chemokine, both important for cell migration. After MI, expression of matrix metalloproteinase-9 was 650% higher and collagen-1 was 53% lower in FXIII–/– mice, establishing an imbalance in extracellular matrix turnover and providing a possible mechanism for the observed cardiac rupture in the FXIII–/– mice.

Conclusions— These data suggest that FXIII has an important role in murine myocardial healing after infarction.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2006 113: 1155. [Full Text]



This article has been cited by other articles:


Home page
HypertensionHome page
D. Fraccarollo, P. Galuppo, S. Schraut, S. Kneitz, N. van Rooijen, G. Ertl, and J. Bauersachs
Immediate Mineralocorticoid Receptor Blockade Improves Myocardial Infarct Healing by Modulation of the Inflammatory Response
Hypertension, April 1, 2008; 51(4): 905 - 914.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Shimazaki, K. Nakamura, I. Kii, T. Kashima, N. Amizuka, M. Li, M. Saito, K. Fukuda, T. Nishiyama, S. Kitajima, et al.
Periostin is essential for cardiac healingafter acute myocardial infarction
J. Exp. Med., February 18, 2008; 205(2): 295 - 303.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
D. Vanhoutte and S. Heymans
Factor XIII: the cement of the heart after myocardial infarction?
Eur. Heart J., February 2, 2008; 29(4): 427 - 428.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M. Nahrendorf, E. Aikawa, J.-L. Figueiredo, L. Stangenberg, S. W. van den Borne, W. M. Blankesteijn, D. E. Sosnovik, F. A. Jaffer, C.-H. Tung, and R. Weissleder
Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for FXIII therapy and antithrombin use in myocardial infarction
Eur. Heart J., February 2, 2008; 29(4): 445 - 454.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
K. Urayama, C. Guilini, N. Messaddeq, K. Hu, M. Steenman, H. Kurose, G. Ert, and C. G. Nebigil
The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis
FASEB J, September 1, 2007; 21(11): 2980 - 2993.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
Y. Nakano, H. F. Al-Jallad, A. Mousa, and M. T. Kaartinen
Expression and Localization of Plasma Transglutaminase Factor XIIIA in Bone
J. Histochem. Cytochem., July 1, 2007; 55(7): 675 - 685.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Nahrendorf, C. Badea, L. W. Hedlund, J.-L. Figueiredo, D. E. Sosnovik, G. A. Johnson, and R. Weissleder
High-resolution imaging of murine myocardial infarction with delayed-enhancement cine micro-CT
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3172 - H3178.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Nahrendorf, D. E. Sosnovik, P. Waterman, F. K. Swirski, A. N. Pande, E. Aikawa, J.-L. Figueiredo, M. J. Pittet, and R. Weissleder
Dual Channel Optical Tomographic Imaging of Leukocyte Recruitment and Protease Activity in the Healing Myocardial Infarct
Circ. Res., April 27, 2007; 100(8): 1218 - 1225.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. E. Sosnovik, M. Nahrendorf, N. Deliolanis, M. Novikov, E. Aikawa, L. Josephson, A. Rosenzweig, R. Weissleder, and V. Ntziachristos
Fluorescence Tomography and Magnetic Resonance Imaging of Myocardial Macrophage Infiltration in Infarcted Myocardium In Vivo
Circulation, March 20, 2007; 115(11): 1384 - 1391.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
S. Frantz, K. Hu, B. Bayer, S. Gerondakis, J. Strotmann, A. Adamek, G. Ertl, and J. Bauersachs
Absence of NF-{kappa}B subunit p50 improves heart failure after myocardial infarction
FASEB J, September 1, 2006; 20(11): 1918 - 1920.
[Abstract] [Full Text] [PDF]